Company Description

Kbio, formerly Kentucky Bioprocessing and a subsidiary of BAT, aims to create a new generation of biologics using its plant-based platform, which has demonstrated its ability to produce novel antibody and vaccine candidates with high purityi at a fraction of the time and cost of current technologies.